Turning Discovery into Precision Health

TRANSFORM: To Make Real Change

Scientific breakthroughs create the greatest value when they extend beyond discovery to improve our understanding of biology and ultimately advance precision health.Today, advances in proteomics are enabling researchers to translate molecular insights into meaningful biological and clinical applications, accelerating the journey from scientific discovery to clinical implementation.

In this final chapter of the Ride the Wave: Innovation Now for Precision Health webinar series, you'll hear how leading scientists are bridging the gap between discovery and implementation. Through examples in translational research, biomarker development, and clinical application, our speakers will demonstrate how proteomics is helping shape the future of precision health.

Featured Speakers

• Jennifer Van Eyk Transforming Discovery into Clinical Impact

Dr. Jennifer Van Eyk will discuss the journey from proteomic discovery to clinical implementation, highlighting the scientific and practical considerations required to translate promising biomarkers into tools that can improve patient care.

• Yu-Ju Chen Emerging Opportunities for Population-scale Proteomics

Dr. Yu-Ju Chen will share her experience translating proteomics assays into clinical practice, highlighting the scientific, technical, and implementation challenges encountered along the way. Through lessons learned and emerging opportunities, she will explore how proteomics is advancing precision health.

What You'll Learn

• Explore how proteomics is accelerating the translation of scientific discoveries into clinical applications.
• Understand the scientific and practical challenges of implementing proteomics in clinical research and precision health.
• Leave inspired by how translational proteomics is helping shape the future of precision health.

Presenter: Jennifer Van Eyk, PhD (Professor, Director, Cedars-Sinai, Smidt Heart Institute)

Dr. Jennifer Van Eyk is a Professor of Medicine and Biomedical Sciences at Cedars-Sinai and Director of the Advanced Clinical Biosystems Research Institute. A pioneer in clinical proteomics and past president of the Human Proteome Organization (HUPO), she advances precision medicine through biomarker discovery and translational proteomics.

Presenter: Yu-Ju Chen, PhD (Distinguished Research Fellow, Academia Sinica)

Dr. Yu-Ju Chen, is a Distinguished Research Fellow and Director of the Institute of Chemistry at Academia Sinica in Taiwan. A pioneer in translational proteomics, her research integrates advanced mass spectrometry, systems biology, and clinical research to accelerate biomarker discovery and precision health. Through leadership of large-scale collaborative initiatives, Dr. Chen is helping shape the future of proteomics by translating scientific innovation into meaningful biological and clinical impact.

Moderator: Stephanie Samra (Sr. Manager, Translational Research, Thermo Fisher Scientific)

Stephanie Samra is the Senior Market Development Manager for the Translational Research Program at Thermo Fisher Scientific, where she leads global market development initiatives supporting the translational proteomics community. With more than 15 years of experience in analytical chemistry and mass spectrometry, she specializes in LC-MS/MS workflows spanning metabolomics, clinical research, and translational science. As host of the Ride the Wave webinar series, Stephanie brings together leading researchers to explore the bold ideas, enabling technologies, and transformational discoveries shaping the future of precision health.